Yangyang Li

机构：University of Science and Technology of China, University of Electronic Science and Technology of China, Army Medical University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, ShanghaiTech University, Daping Hospital, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Sichuan Provincial Hospital of Traditional Chinese Medicine, Pharmaceutical Biotechnology (Czechia) · ORCID：0000-0002-5791-9443

发表论文 143 篇 · 总被引 3022 次 · h-index 27

代表论文

• Multifaceted regulatory mechanisms of the EGR family in tumours and prospects for therapeutic applications (Review) (2025 · International Journal of Molecular Medicine · 被引 11)
• Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy (2026 · Medicine Bulletin · 被引 8)
• Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections (2025 · Frontiers in Cellular and Infection Microbiology · 被引 8)
• Hydroxytyrosol induced ferroptosis through Nrf2 signaling pathway in colorectal cancer cells (2025 · Scientific Reports · 被引 6)
• Menstrual blood-derived endometrial stem cells ameliorate neuroinflammation and apoptosis through JAK2/STAT3 signaling pathway in NPC1 mutant cell and mice (2025 · Stem Cell Research & Therapy · 被引 5)
• Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases (2025 · World Journal of Stem Cells · 被引 3)